跳转至内容
Merck
CN

HCYTABM-17K

MILLIPLEX® Human Cytokine Autoantibody Panel

Configurable Human Cytokine Autoantibody IgM 23-Plex Panel

登录 查看组织和合同定价。

关于此项目

NACRES:
NA.84
UNSPSC Code:
12161503


产品名称

MILLIPLEX® Human Cytokine Autoantibody Panel,

description

Configurable Human Cytokine Autoantibody IgM 23-Plex Panel

Quality Level

species reactivity

human

packaging

pkg of 1 ea

manufacturer/tradename

Milliplex®

technique(s)

multiplexing: suitable

input

plasma
serum

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

General description

Anti-cytokine antibodies occur frequently and are present in healthy individuals and patients with acquired immunodeficiency and autoimmune diseases. Cytokines offering protection against microbes can be targeted by cytokine autoantibodies, leading to life-threatening infections. Some infections associated with anti-cytokine antibodies include M. tuberculosis, Salmonella, S. aureus. E. coli, Histoplasma, and more. The presence of cytokine autoantibodies in autoimmune disease can influence disease severity and activity. These autoimmune diseases may include systemic lupus erythematosus, multiple sclerosis, Sjögren′s syndrome, rheumatoid arthritis, and acute respiratory distress syndrome.

Application

MILLIPLEX® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze up to 23 analytes in human serum and plasma samples.

Analytes included: Anti-BAFF, Anti-G-CSF, Anti-IFNβ, Anti-IFNγ, Anti-IL-1α, Anti-IL-6, Anti IL 8, Anti-IL-10, Anti-IL-12p40, Anti-IL-15, Anti-IL-17A, Anti-IL-17F, Anti-IL-18, Anti-IL-22, Anti-TNFα, Anti-IFNα2, Anti-GM-CSF, Anti-IL-2, Anti-IL-3, Anti-IL-4, Anti-Osteopontin, Anti-PF4, and Anti-IFNψ

Note: This is a qualitative assay.

Assay Characteristics: Refer to kit protocol for assay cross-reactivity and precision.

Features and Benefits

  • Qualitative Detection: Provides reliable presence/absence determination of cytokine autoantibodies, supporting research classification and biomarker discovery studies.
  • Early Immune Response Detection: Capture IgM cytokine autoantibodies representing primary immune responses and early-stage autoimmune processes, enabling investigation of disease initiation and acute immune dysfunction.
  • Acute Phase Investigation: Monitor IgM autoantibodies during acute disease flares and initial immune system activation in research studies of autoimmune disease progression.
  • Comprehensive Immune Profiling: Combined use of IgG, IgM, and IgA panels provides complete temporal and functional assessment of cytokine autoantibody responses in research applications.

Legal Information

Luminex is a registered trademark of Luminex Corporation
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Disclaimer

For research use only. Not for use in diagnostic procedures.

Label License/Sticker for Assay Product:

By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.


Still not finding the right product?

Explore all of our products under


pictograms

Exclamation markEnvironment

signalword

Warning

Hazard Classifications

Aquatic Chronic 2 - Eye Irrit. 2 - Skin Sens. 1

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

存储类别

12 - Non Combustible Liquids

法规信息

新产品

此项目有



分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库